390 related articles for article (PubMed ID: 20552235)
1. Motor neuron-immune interactions: the vicious circle of ALS.
Barbeito AG; Mesci P; Boillée S
J Neural Transm (Vienna); 2010 Aug; 117(8):981-1000. PubMed ID: 20552235
[TBL] [Abstract][Full Text] [Related]
2. Innate immunity in amyotrophic lateral sclerosis.
Moisse K; Strong MJ
Biochim Biophys Acta; 2006; 1762(11-12):1083-93. PubMed ID: 16624536
[TBL] [Abstract][Full Text] [Related]
3. Purinergic implication in amyotrophic lateral sclerosis-from pathological mechanisms to therapeutic perspectives.
Cieślak M; Roszek K; Wujak M
Purinergic Signal; 2019 Mar; 15(1):1-15. PubMed ID: 30430356
[TBL] [Abstract][Full Text] [Related]
4. Modifying macrophages at the periphery has the capacity to change microglial reactivity and to extend ALS survival.
Chiot A; Zaïdi S; Iltis C; Ribon M; Berriat F; Schiaffino L; Jolly A; de la Grange P; Mallat M; Bohl D; Millecamps S; Seilhean D; Lobsiger CS; Boillée S
Nat Neurosci; 2020 Nov; 23(11):1339-1351. PubMed ID: 33077946
[TBL] [Abstract][Full Text] [Related]
5. Immune reactivity in a mouse model of familial ALS correlates with disease progression.
Alexianu ME; Kozovska M; Appel SH
Neurology; 2001 Oct; 57(7):1282-9. PubMed ID: 11591849
[TBL] [Abstract][Full Text] [Related]
6. Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.
Philips T; Robberecht W
Lancet Neurol; 2011 Mar; 10(3):253-63. PubMed ID: 21349440
[TBL] [Abstract][Full Text] [Related]
7. Neuroinflammation in the pathogenesis of amyotrophic lateral sclerosis.
Weydt P; Möller T
Neuroreport; 2005 Apr; 16(6):527-31. PubMed ID: 15812300
[TBL] [Abstract][Full Text] [Related]
8. Immune-mediated mechanisms in the pathoprogression of amyotrophic lateral sclerosis.
Zhao W; Beers DR; Appel SH
J Neuroimmune Pharmacol; 2013 Sep; 8(4):888-99. PubMed ID: 23881705
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotective effects of the Sigma-1 receptor (S1R) agonist PRE-084, in a mouse model of motor neuron disease not linked to SOD1 mutation.
Peviani M; Salvaneschi E; Bontempi L; Petese A; Manzo A; Rossi D; Salmona M; Collina S; Bigini P; Curti D
Neurobiol Dis; 2014 Feb; 62():218-32. PubMed ID: 24141020
[TBL] [Abstract][Full Text] [Related]
10. Rapidly progressive amyotrophic lateral sclerosis is associated with microglial reactivity and small heat shock protein expression in reactive astrocytes.
Gorter RP; Stephenson J; Nutma E; Anink J; de Jonge JC; Baron W; Jahreiβ MC; Belien JAM; van Noort JM; Mijnsbergen C; Aronica E; Amor S
Neuropathol Appl Neurobiol; 2019 Aug; 45(5):459-475. PubMed ID: 30346063
[TBL] [Abstract][Full Text] [Related]
11. The Overexpression of TDP-43 Protein in the Neuron and Oligodendrocyte Cells Causes the Progressive Motor Neuron Degeneration in the SOD1 G93A Transgenic Mouse Model of Amyotrophic Lateral Sclerosis.
Lu Y; Tang C; Zhu L; Li J; Liang H; Zhang J; Xu R
Int J Biol Sci; 2016; 12(9):1140-9. PubMed ID: 27570488
[TBL] [Abstract][Full Text] [Related]
12. Interleukin-17 and Th17 Lymphocytes Directly Impair Motoneuron Survival of Wildtype and FUS-ALS Mutant Human iPSCs.
Jin M; Akgün K; Ziemssen T; Kipp M; Günther R; Hermann A
Int J Mol Sci; 2021 Jul; 22(15):. PubMed ID: 34360808
[TBL] [Abstract][Full Text] [Related]
13. Neuron-Microglia Interactions in Motor Neuron Degeneration. The Inflammatory Hypothesis in Amyotrophic Lateral Sclerosis Revisited.
Rodríguez MJ; Mahy N
Curr Med Chem; 2016; 23(42):4753-4772. PubMed ID: 27881068
[TBL] [Abstract][Full Text] [Related]
14. Innate and adaptive immunity in amyotrophic lateral sclerosis: evidence of complement activation.
Sta M; Sylva-Steenland RM; Casula M; de Jong JM; Troost D; Aronica E; Baas F
Neurobiol Dis; 2011 Jun; 42(3):211-20. PubMed ID: 21220013
[TBL] [Abstract][Full Text] [Related]
15. Mutant SOD1 prevents normal functional recovery through enhanced glial activation and loss of motor neuron innervation after peripheral nerve injury.
Schram S; Chuang D; Schmidt G; Piponov H; Helder C; Kerns J; Gonzalez M; Song F; Loeb JA
Neurobiol Dis; 2019 Apr; 124():469-478. PubMed ID: 30594811
[TBL] [Abstract][Full Text] [Related]
16. Natural killer cells modulate motor neuron-immune cell cross talk in models of Amyotrophic Lateral Sclerosis.
Garofalo S; Cocozza G; Porzia A; Inghilleri M; Raspa M; Scavizzi F; Aronica E; Bernardini G; Peng L; Ransohoff RM; Santoni A; Limatola C
Nat Commun; 2020 Apr; 11(1):1773. PubMed ID: 32286313
[TBL] [Abstract][Full Text] [Related]
17. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
Mesci P; Zaïdi S; Lobsiger CS; Millecamps S; Escartin C; Seilhean D; Sato H; Mallat M; Boillée S
Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
[TBL] [Abstract][Full Text] [Related]
18. Macrophage-mediated inflammation and glial response in the skeletal muscle of a rat model of familial amyotrophic lateral sclerosis (ALS).
Van Dyke JM; Smit-Oistad IM; Macrander C; Krakora D; Meyer MG; Suzuki M
Exp Neurol; 2016 Mar; 277():275-282. PubMed ID: 26775178
[TBL] [Abstract][Full Text] [Related]
19. Ablation of proliferating microglia does not affect motor neuron degeneration in amyotrophic lateral sclerosis caused by mutant superoxide dismutase.
Gowing G; Philips T; Van Wijmeersch B; Audet JN; Dewil M; Van Den Bosch L; Billiau AD; Robberecht W; Julien JP
J Neurosci; 2008 Oct; 28(41):10234-44. PubMed ID: 18842883
[TBL] [Abstract][Full Text] [Related]
20. Serotonin 2B receptor slows disease progression and prevents degeneration of spinal cord mononuclear phagocytes in amyotrophic lateral sclerosis.
El Oussini H; Bayer H; Scekic-Zahirovic J; Vercruysse P; Sinniger J; Dirrig-Grosch S; Dieterlé S; Echaniz-Laguna A; Larmet Y; Müller K; Weishaupt JH; Thal DR; van Rheenen W; van Eijk K; Lawson R; Monassier L; Maroteaux L; Roumier A; Wong PC; van den Berg LH; Ludolph AC; Veldink JH; Witting A; Dupuis L
Acta Neuropathol; 2016 Mar; 131(3):465-80. PubMed ID: 26744351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
